Work

Phase I study of the novel pro-drug MIV-818 in patients with hepatocellular carcinoma, intra-hepatic cholangiocarcinoma or liver metastases.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.3_suppl.309

Authors: T.R. Jeffry Evans, Eric Van Cutsem, Hans Prenen, Mark R. Middleton, Debashis Sarker, Karin Tunblad, Fredrik Oberg, Tom Morris, Linda Basse, Elizabeth Ruth Plummer

Institutions: Beatson West of Scotland Cancer Centre, University of Glasgow, Universitair Ziekenhuis Leuven, KU Leuven, Antwerp University Hospital, Churchill Hospital, King's College Hospital, Medivir (Sweden)

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3124530398

Cites:

Cited by: 2

Related to: 10